MDT

89.73

+0.97%↑

VEEV

279.27

-0.27%↓

A

114.7

+0.11%↑

WBA

11.5

-0.17%↓

HQY

98.39

-0.56%↓

MDT

89.73

+0.97%↑

VEEV

279.27

-0.27%↓

A

114.7

+0.11%↑

WBA

11.5

-0.17%↓

HQY

98.39

-0.56%↓

MDT

89.73

+0.97%↑

VEEV

279.27

-0.27%↓

A

114.7

+0.11%↑

WBA

11.5

-0.17%↓

HQY

98.39

-0.56%↓

MDT

89.73

+0.97%↑

VEEV

279.27

-0.27%↓

A

114.7

+0.11%↑

WBA

11.5

-0.17%↓

HQY

98.39

-0.56%↓

MDT

89.73

+0.97%↑

VEEV

279.27

-0.27%↓

A

114.7

+0.11%↑

WBA

11.5

-0.17%↓

HQY

98.39

-0.56%↓

Search

10X Genomics Inc (Class A)

Uždarymo kaina

SektoriusSveikatos priežiūra

12.44 0.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.3

Max

12.54

Pagrindiniai rodikliai

By Trading Economics

Pajamos

15M

-34M

Pardavimai

-10M

155M

Pelno marža

-22.183

Darbuotojai

1,306

EBITDA

-1.5M

-39M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+10.19% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

475M

1.5B

Ankstesnė atidarymo kaina

11.87

Ankstesnė uždarymo kaina

12.44

Naujienos nuotaikos

By Acuity

34%

66%

108 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

10X Genomics Inc (Class A) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-17 23:34; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

2025-07-17 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

2025-07-17 21:04; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

2025-07-17 23:43; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025-07-17 23:42; UTC

Rinkos pokalbiai

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

2025-07-17 22:47; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:30; UTC

Rinkos pokalbiai
Uždarbis

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

2025-07-17 22:04; UTC

Rinkos pokalbiai
Uždarbis

Netflix Redesign Done to Match Current Capabilities -- Market Talk

2025-07-17 22:03; UTC

Įsigijimai, susijungimai, perėmimai

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

2025-07-17 21:58; UTC

Rinkos pokalbiai
Uždarbis

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

2025-07-17 21:57; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:47; UTC

Uždarbis

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

2025-07-17 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-17 21:45; UTC

Rinkos pokalbiai

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

2025-07-17 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

2025-07-17 21:22; UTC

Įsigijimai, susijungimai, perėmimai

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 21:05; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:04; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

2025-07-17 21:02; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

2025-07-17 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-07-17 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

10X Genomics Inc (Class A) Prognozė

Kainos tikslas

By TipRanks

10.19% į viršų

12 mėnesių prognozė

Vidutinis 13.63 USD  10.19%

Aukščiausias 18 USD

Žemiausias 9 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines 10X Genomics Inc (Class A) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

4

Pirkti

6

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

8.32 / 8.63Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

108 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.